The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion
Launched by NOVA SCOTIA HEALTH AUTHORITY · Jul 14, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how weight bearing, or putting weight on your foot, affects recovery after a specific type of foot surgery called first metatarsophalangeal (MTP) joint fusion. This surgery is often recommended for people with conditions like Hallux Valgus (bunion) or Hallux Rigidus (stiff big toe) when other treatments, like orthotics or pain medication, haven’t worked. The trial is currently recruiting participants aged 18 and older who are healthy enough for surgery and have been diagnosed with these conditions.
If you decide to participate, you will undergo the MTP joint fusion surgery and then follow a specific weight-bearing plan during your recovery. You will also need to attend follow-up appointments to monitor your progress. It’s important that you can commit to this follow-up schedule and that you understand what the study involves, as you will be asked to provide your consent before joining. This trial aims to find out the best approach to help people recover after their surgery, potentially leading to better outcomes for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 years or great
- • Medically fit for surgery
- • Patients diagnosed with condition for which a 1st MTP joint fusion is a surgical management option based on clinical examination and radiographs
- • Failed non-operative management (orthotics, bracing, Tylenol, NSAIDs, shoe-wear modification)
- • Surgery is for an isolated 1st MTP fusion
- • Able and willing to comply with follow up schedule and requirements
- • Capable of providing informed consent
- Exclusion Criteria:
- • Age \<18 years old
- • Surgical booking is for more than just 1st MTP fusion
- • Unable to comply with follow up schedule and requirements
- • Unable to provide informed consent
About Nova Scotia Health Authority
The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Patients applied
Trial Officials
Mark Glazebrook, MD FRCS
Principal Investigator
NSHA\ Dalhousie UNiversity
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials